BioSig Technologies (BSGM) Competitors $3.30 +0.24 (+7.84%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$3.42 +0.12 (+3.64%) As of 05/21/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BSGM vs. NYXH, DRTS, ELMD, RCEL, CATX, INGN, LAKE, BWAY, SGHT, and TLSIShould you be buying BioSig Technologies stock or one of its competitors? The main competitors of BioSig Technologies include Nyxoah (NYXH), Alpha Tau Medical (DRTS), Electromed (ELMD), AVITA Medical (RCEL), Perspective Therapeutics (CATX), Inogen (INGN), Lakeland Industries (LAKE), BrainsWay (BWAY), Sight Sciences (SGHT), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry. BioSig Technologies vs. Nyxoah Alpha Tau Medical Electromed AVITA Medical Perspective Therapeutics Inogen Lakeland Industries BrainsWay Sight Sciences TriSalus Life Sciences Nyxoah (NASDAQ:NYXH) and BioSig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment, community ranking and valuation. Is NYXH or BSGM more profitable? Nyxoah has a net margin of -1,043.93% compared to BioSig Technologies' net margin of -44,832.50%. BioSig Technologies' return on equity of 0.00% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-1,043.93% -51.68% -40.11% BioSig Technologies -44,832.50%N/A -776.49% Does the MarketBeat Community believe in NYXH or BSGM? BioSig Technologies received 62 more outperform votes than Nyxoah when rated by MarketBeat users. However, 73.68% of users gave Nyxoah an outperform vote while only 70.75% of users gave BioSig Technologies an outperform vote. CompanyUnderperformOutperformNyxoahOutperform Votes4273.68% Underperform Votes1526.32% BioSig TechnologiesOutperform Votes10470.75% Underperform Votes4329.25% Do analysts recommend NYXH or BSGM? Nyxoah currently has a consensus price target of $14.50, indicating a potential upside of 80.12%. BioSig Technologies has a consensus price target of $2.50, indicating a potential downside of 24.24%. Given Nyxoah's higher probable upside, analysts clearly believe Nyxoah is more favorable than BioSig Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00BioSig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation & earnings, NYXH or BSGM? BioSig Technologies has lower revenue, but higher earnings than Nyxoah. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$4.36M62.83-$46.77M-$2.13-3.78BioSig Technologies$40K2,000.79-$29.04MN/AN/A Does the media prefer NYXH or BSGM? In the previous week, Nyxoah had 2 more articles in the media than BioSig Technologies. MarketBeat recorded 6 mentions for Nyxoah and 4 mentions for BioSig Technologies. Nyxoah's average media sentiment score of 0.08 beat BioSig Technologies' score of -0.75 indicating that Nyxoah is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nyxoah 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BioSig Technologies 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Which has more risk and volatility, NYXH or BSGM? Nyxoah has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500. Comparatively, BioSig Technologies has a beta of 0.02, indicating that its stock price is 98% less volatile than the S&P 500. Do institutionals & insiders have more ownership in NYXH or BSGM? 7.2% of BioSig Technologies shares are owned by institutional investors. 17.1% of Nyxoah shares are owned by insiders. Comparatively, 17.0% of BioSig Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryNyxoah beats BioSig Technologies on 10 of the 15 factors compared between the two stocks. Get BioSig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBioSig TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$80.03M$3.26B$5.37B$8.39BDividend YieldN/A1.73%5.22%4.10%P/E RatioN/A16.6026.8419.71Price / Sales2,000.7985.43392.34117.39Price / CashN/A44.0938.2534.62Price / Book-10.003.736.794.50Net Income-$29.04M$94.03M$3.23B$248.18M7 Day Performance29.41%0.75%1.53%0.20%1 Month Performance465.07%20.87%10.06%12.37%1 Year Performance104.97%-12.91%16.72%7.04% BioSig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBioSig Technologies0.3674 of 5 stars$3.30+7.8%$2.50-24.2%+79.3%$80.03M$40,000.000.0050Earnings ReportGap UpNYXHNyxoah2.897 of 5 stars$5.98-5.1%$14.50+142.5%-19.5%$203.68M$4.52M-3.20110Gap UpDRTSAlpha Tau Medical1.9895 of 5 stars$2.80-5.1%$8.00+185.7%+14.3%$197.07MN/A-6.5180Earnings ReportGap UpELMDElectromed1.2106 of 5 stars$22.44+0.8%$38.00+69.3%+24.4%$192.02M$59.63M29.92160Positive NewsRCELAVITA Medical1.2748 of 5 stars$7.25+4.0%$17.25+137.9%-19.9%$191.65M$64.25M-3.03130Gap UpHigh Trading VolumeCATXPerspective Therapeutics3.4326 of 5 stars$2.51+6.8%$12.75+408.0%-84.4%$185.87M$1.43M0.0070News CoverageAnalyst RevisionGap DownINGNInogen3.425 of 5 stars$6.30+1.0%$7.00+11.1%-30.8%$169.39M$335.71M-2.801,030Gap UpLAKELakeland Industries4.7803 of 5 stars$17.76+4.1%$27.00+52.0%+6.5%$168.92M$167.21M-197.331,800News CoverageGap DownBWAYBrainsWay3.6027 of 5 stars$8.83+1.4%$14.25+61.4%+91.5%$166.64M$41.02M88.31120Positive NewsGap UpSGHTSight Sciences3.3854 of 5 stars$3.21+4.2%$3.92+22.0%-40.7%$165.94M$79.87M-3.15210Gap UpTLSITriSalus Life Sciences2.5799 of 5 stars$5.11+1.8%$10.93+113.9%-45.4%$164.91M$29.43M-2.05106Positive NewsEarnings ReportAnalyst Revision Related Companies and Tools Related Companies Nyxoah Competitors Alpha Tau Medical Competitors Electromed Competitors AVITA Medical Competitors Perspective Therapeutics Competitors Inogen Competitors Lakeland Industries Competitors BrainsWay Competitors Sight Sciences Competitors TriSalus Life Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BSGM) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
